Highlights COSMOS Pharmaceutical Corporation

Equities

3349

JP3298400007

Market Closed - Japan Exchange Other stock markets 07:00:00 10/05/2024 BST			5-day change	1st Jan Change
13,655 ^JPY	-5.37%		-7.11%	-16.15%

04-12	Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	MT
01-12	Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	04-12	MT
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	04-12	CI
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	01-12	MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	01-12	CI
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	01-12	CI
Ex-dividend day for interim dividend	11-28	FA
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	12/10/23	MT
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	11/10/23	CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	11/10/23	CI
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	11/07/23	MT
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	10/07/23	CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	10/07/23	CI
Ex-dividend day for final dividend	29/05/23	FA
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	11/04/23	MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10/04/23	CI
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	10/04/23	CI
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	16/01/23	MT
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023	13/01/23	CI
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023	13/01/23	CI
Ex-dividend day for interim dividend	28/11/22	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights COSMOS Pharmaceutical Corporation

Equities

3349

JP3298400007

Highlights

Filters